AAPG · US market
Ascentage Pharma Group International USD0.0001
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$5.94bnFinancials dated 31 December 2024Price dated 1 October 2026
Core valuation
* P/E uses the latest reported full year ended 31 December 2024 because neither a trailing four-quarter value nor a latest-quarter value is available.
* P/S uses the latest reported full year ended 31 December 2024 because neither a trailing four-quarter value nor a latest-quarter value is available.
Calculation inputs
- Trailing earnings
- Unavailable
- Latest-quarter run-rate earnings
- Unavailable
- Latest fiscal-year earnings
- -US$55.54m
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- US$134.35m
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 December 2024. Informational research, not investment advice.